NDC 49288-0146

Cattail

Cattail

Cattail is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Antigen Laboratories, Inc.. The primary component is Typha Latifolia Pollen.

• Product ID: 49288-0146_0247493a-8221-44f5-afa6-071bde3bfac2
• NDC: 49288-0146
• Product Type: Human Prescription Drug
• Proprietary Name: Cattail
• Generic Name: Cattail
• Dosage Form: Injection, Solution
• Route of Administration: INTRADERMAL; SUBCUTANEOUS
• Marketing Start Date: 1974-03-23
• Marketing Category: BLA / BLA
• Application Number: BLA102223
• Labeler Name: Antigen Laboratories, Inc.
• Substance Name: TYPHA LATIFOLIA POLLEN
• Active Ingredient Strength: 0 g/mL
• Pharm Classes: Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE]
• NDC Exclude Flag: E
• Listing Certified Through: 2017-12-31

Packaging

NDC 49288-0146-2

5 mL in 1 VIAL, MULTI-DOSE (49288-0146-2)

• Marketing Start Date: 1974-03-23
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 49288-0146-4 [49288014604]

Cattail INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA102223
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 1974-03-23
• Inactivation Date: 2019-10-21

NDC 49288-0146-3 [49288014603]

Cattail INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA102223
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 1974-03-23
• Inactivation Date: 2019-10-21

NDC 49288-0146-5 [49288014605]

Cattail INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA102223
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 1974-03-23
• Inactivation Date: 2019-10-21

NDC 49288-0146-1 [49288014601]

Cattail INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA102223
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 1974-03-23
• Inactivation Date: 2019-10-21

NDC 49288-0146-2 [49288014602]

Cattail INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA102223
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 1974-03-23
• Inactivation Date: 2019-10-21

Drug Details

Active Ingredients

Ingredient	Strength
TYPHA LATIFOLIA POLLEN	.05 g/mL

OpenFDA Data

• SPL SET ID: c7d383a6-94b8-4101-8a4c-fa7747a21468
• Manufacturer:
  • Antigen Laboratories, Inc.
• UNII:
  • 70O1TP6H01
  • B55BD1QM4Q
  • 50HCQ1NYV5
  • 766QT72BK6
  • 341PDX5PLM
  • GOA51670YV
  • 74PD8J616H
  • 577VA5B4HP
  • V003SHB7VK
  • W7NU4B5CIY
  • FAY1Y90VJ9
  • 6AU0ZD8T1O
  • A7IKY24TR7
  • Q4T1SJ3046
  • 7U437HHU5C
  • F1KAH8374D
  • 9L67M8B78R
  • ON2T85TA2O
  • I6KAZ8AO1O
  • UVC3Z60VTX
• RxNorm Concept Unique ID - RxCUI:
  • 889573
  • 852676
  • 852517
  • 852346
  • 852228
  • 852220
  • 1232641
  • 1006509
  • 1115952
  • 889671
  • 898407
  • 1098458
  • 852117
  • 852018
  • 852332
  • 852662
  • 852139
  • 852135
  • 1014777
  • 1014738
  • 1014734
  • 852700
  • 898132

Pharmacological Class

• Cell-mediated Immunity [PE]
• Increased IgG Production [PE]
• Pollen [CS]
• Allergens [CS]
• Non-Standardized Pollen Allergenic Extract [EPC]
• Increased Histamine Release [PE]